Hypertensive disorders of pregnancy

Danforth's Obstetrics and Gynecology: Tenth Edition

Volumn , Issue , 2012, Pages 257-275

  Habli, Mounira ^a   Sibai, Baha M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84969909589     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (35)

1. Abramovici D, Friedman SA, Mercer BM, et al. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation:does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?. Am J Obstet Gynecol 1999;180:221-225.
2. American College of Obstetricians and Gynecologists. Chronic hypertension in pregnancy. ACOG Practice Bulletin No. 29. Obstet Gynecol 2001;98:177-185.
3. American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33. Obstet Gynecol 2002;99:159-167.
4. Audibert F, Friedman SA, Frangieh AY, et al. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996;175:460- 464.
5. Barton JR, Bergauer NK, Jacques DL, et al. Does advanced maternal age effect pregnancy outcome in women with mild hypertension remote from term?. Am J Obstet Gynecol 1997;176:1236-1243.
6. Barton JR, O'Brien JM, Bergauer NK, et al. Mild gestational hypertension remote from term:progression and outcome. Am J Obstet Gynecol 2001;184:979-983.
7. Briggs R, Chari RS, Mercer B, et al. Postoperative incision complications after cesarean section in patients with antepartum syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP):does delayed primary closure make a difference?. Am J Obstet Gynecol 1996;175:893-896.
8. Caritis, S, Sibai B, Hauth J, et al., and the National Institute of Child Health and Human DevelopmentNetworkofMaternal-Fetal Medicine Units. Predictors of pre-eclampsia in women at high-risk. Am J Obstet Gynecol 1998;179:946-951.
9. Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of preeclampsia in women at increased risk:a randomised trial. Lancet 1999;354:810-816.
10. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia:current concepts. Am J Obstet Gynecol 1998;179:1359-1375.
11. Duley L, Galmezoglu AM, Henderson-Smart DJ. Magnesium sulfate and other anticonvulsants for women with preeclampsia. Cochrane Database Syst Rev 2003;issue 2.
12. Levine RJ, Ewell MG, Hauth JC, et al. Should the definition of preeclampsia include a rise in diastolic blood pressure =15 mm Hg to a level <90 mm Hg in association with proteinuria?. Am J Obstet Gynecol 2000;183:787-792.
13. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-683.
14. Levine RJ, Qian C, Leshane ES, et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004;190:707-713.
15. Martin JN, Perry KG, Blake PG, et al. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol 1997;177:1011-1017.
16. Matchaba P, Moodley J. Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev 2002; issue 4.
17. Mathys LA, Coppage KH, Lambers DS, et al. Delayed postpartum preeclampsia:an experience of 151 cases. Am J Obstet Gynecol 2004;190:1464-1466.
18. MattarF, Sibai BM. Eclampsia VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol 2000;182:307-312.
19. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble FMS-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. Clin Invest 2003;111:649-658.
20. Nisell H, Lintu H, Lunell NO, et al. Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynaecol 1995;102:876-881.
21. O'Brien JM, Milligan DA, Barton JR. Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000;183:921-924.
22. O'Brien JM, Shumate SA, Satchwell SL, et al. Maternal benefit of corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome:impact on the rate of regional anesthesia. Am J Obstet Gynecol 2002;186:475- 479.
23. Parazzini F, Gruppo di Studio Ipertensione in Gravidanza. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Br J Obstet Gynaecol 1998;105:718.
24. Repke JT. Contraception for the woman with hypertension. In:Sibai BM, ed. Hypertensive disorders in women. Philadelphia:WB Saunders, 2001.
25. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
26. Samadi AR, Mayberry RM, Zaidi AA, et al. Maternal hypertension and associated pregnancy complications among African-American and other women in the United States. Obstet Gynecol 1996;87:557- 563.
27. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk:opportunities for intervention and screening?. BMJ 2002;325:157.
28. Sibai BM. Magnesium sulfate prophylaxis in preeclampsia. Lessons learned from recent trials. Am J Obstet Gynecol 2004;190:1520- 1526.
29. Sibai BM. Prevention of preeclampsia:a big disappointment. Am J Obstet Gynecol 1998;179:1275-1278.
30. Sibai BM. Treatment of hypertension in pregnant women. NEngl J Med 1996;335:257-265.
31. Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med 1998;339:667- 671.
32. Sibai BM, Ramadan MK, Chari RS, et al. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets):subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995;172:125- 129.
33. Sibai BM. Diagnosis, controversies, and management of the syndrome HELLP. Obstet Gynecol 2004;103:981-991.
34. Visser W, Wallenburg HCS. Temporising management of severe preeclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995;102:111-117.
35. Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 1998;92:883-889.